Todd C Brady bought $418K of ALDX stock

Todd C Brady, President and CEO of Aldeyra Therapeutics, Inc. (ALDX), bought 250,000 shares of ALDX stock worth $418K, per an SEC Form 4 filed Jun 5, 2026.

It was an open-market purchase.

The trade happened on Jun 3, 2026, 2 days before it was made public.

ALDX has moved -66.1% since the trade date, from $1.86 to $0.63 (Nov 12, 2026 close).